GT Biopharma
GTBP
GTBP
32 hedge funds and large institutions have $850K invested in GT Biopharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BBPWM
26
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $72 | – | – | – |
|
27
Fidelity Investments
Boston,
Massachusetts
| $36 | -$5.49K | -763 | -99% |
|
28
JPMorgan Chase & Co
New York
| $14 | -$595 | -85 | -98% |
|
|
FRA
29
Front Row Advisors
Tiburon,
California
| $14 | – | – | – |
|
|
RG
30
Retirement Group
San Diego,
California
| $11 | – | – | – |
|
31
Jane Street
New York
| – | -$6.4K | -683 | Closed |
|
|
MCG
32
McCollum Christoferson Group
Amherst,
New York
| – | -$5.46K | -583 | Closed |
|
|
CSS
33
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$3.26K | -349 | Closed |
|
|
IA
34
IFP Advisors
Tampa,
Florida
| – | -$16 | -2 | Closed |
|